FIBROBIOLOGICS INC (FBLG) Fundamental Analysis & Valuation

NASDAQ:FBLG • US31573L1052

0.435 USD
+0.02 (+3.77%)
At close: Mar 6, 2026
0.4301 USD
0 (-1.13%)
After Hours: 3/6/2026, 8:15:16 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This FBLG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

0

Taking everything into account, FBLG scores 0 out of 10 in our fundamental rating. FBLG was compared to 520 industry peers in the Biotechnology industry. FBLG may be in some trouble as it scores bad on both profitability and health. FBLG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. FBLG Profitability Analysis

1.1 Basic Checks

  • In the past year FBLG has reported negative net income.
  • FBLG had a negative operating cash flow in the past year.
  • In the past 5 years FBLG always reported negative net income.
  • FBLG had a negative operating cash flow in each of the past 5 years.
FBLG Yearly Net Income VS EBIT VS OCF VS FCFFBLG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 -5M -10M -15M

1.2 Ratios

  • With a Return On Assets value of -211.59%, FBLG is not doing good in the industry: 88.65% of the companies in the same industry are doing better.
  • The Return On Equity of FBLG (-14800.80%) is worse than 82.31% of its industry peers.
Industry RankSector Rank
ROA -211.59%
ROE -14800.8%
ROIC N/A
ROA(3y)-111.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FBLG Yearly ROA, ROE, ROICFBLG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 -500 -1K -1.5K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for FBLG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FBLG Yearly Profit, Operating, Gross MarginsFBLG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. FBLG Health Analysis

2.1 Basic Checks

  • FBLG has more shares outstanding than it did 1 year ago.
  • There is no outstanding debt for FBLG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
FBLG Yearly Shares OutstandingFBLG Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M
FBLG Yearly Total Debt VS Total AssetsFBLG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • FBLG has an Altman-Z score of -13.12. This is a bad value and indicates that FBLG is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of FBLG (-13.12) is worse than 77.69% of its industry peers.
  • A Debt/Equity ratio of 36.58 is on the high side and indicates that FBLG has dependencies on debt financing.
  • FBLG has a worse Debt to Equity ratio (36.58) than 82.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 36.58
Debt/FCF N/A
Altman-Z -13.12
ROIC/WACCN/A
WACCN/A
FBLG Yearly LT Debt VS Equity VS FCFFBLG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 5M -5M -10M -15M

2.3 Liquidity

  • FBLG has a Current Ratio of 0.78. This is a bad value and indicates that FBLG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • FBLG's Current ratio of 0.78 is on the low side compared to the rest of the industry. FBLG is outperformed by 88.08% of its industry peers.
  • A Quick Ratio of 0.78 indicates that FBLG may have some problems paying its short term obligations.
  • The Quick ratio of FBLG (0.78) is worse than 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.78
FBLG Yearly Current Assets VS Current LiabilitesFBLG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 5M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. FBLG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 45.73% over the past year.
EPS 1Y (TTM)45.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • FBLG is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -13.84% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-37.5%
EPS Next 2Y-0.37%
EPS Next 3Y7.3%
EPS Next 5Y-13.84%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FBLG Yearly Revenue VS EstimatesFBLG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 200M 400M 600M
FBLG Yearly EPS VS EstimatesFBLG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. FBLG Valuation Analysis

4.1 Price/Earnings Ratio

  • FBLG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FBLG. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FBLG Price Earnings VS Forward Price EarningsFBLG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FBLG Per share dataFBLG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.37%
EPS Next 3Y7.3%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. FBLG Dividend Analysis

5.1 Amount

  • No dividends for FBLG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

FBLG Fundamentals: All Metrics, Ratios and Statistics

FIBROBIOLOGICS INC

NASDAQ:FBLG (3/6/2026, 8:15:16 PM)

After market: 0.4301 0 (-1.13%)

0.435

+0.02 (+3.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-24
Earnings (Next)05-12
Inst Owners6.63%
Inst Owner Change-19.4%
Ins Owners9.31%
Ins Owner Change2.26%
Market Cap29.40M
Revenue(TTM)N/A
Net Income(TTM)-18.50M
Analysts82.22
Price Target7.14 (1541.38%)
Short Float %1.15%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-11.57%
Min EPS beat(2)-18.56%
Max EPS beat(2)-4.58%
EPS beat(4)1
Avg EPS beat(4)-11.49%
Min EPS beat(4)-24.78%
Max EPS beat(4)1.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.2%
PT rev (3m)-20%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.78%
EPS NY rev (1m)1.23%
EPS NY rev (3m)-2.19%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 231.49
P/tB 231.49
EV/EBITDA N/A
EPS(TTM)-0.48
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -211.59%
ROE -14800.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-111.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 36.58
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 160.44%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.78
Altman-Z -13.12
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
EPS Next Y-37.5%
EPS Next 2Y-0.37%
EPS Next 3Y7.3%
EPS Next 5Y-13.84%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-42.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-157.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-172.96%
OCF growth 3YN/A
OCF growth 5YN/A

FIBROBIOLOGICS INC / FBLG FAQ

Can you provide the ChartMill fundamental rating for FIBROBIOLOGICS INC?

ChartMill assigns a fundamental rating of 0 / 10 to FBLG.


What is the valuation status of FIBROBIOLOGICS INC (FBLG) stock?

ChartMill assigns a valuation rating of 0 / 10 to FIBROBIOLOGICS INC (FBLG). This can be considered as Overvalued.


What is the profitability of FBLG stock?

FIBROBIOLOGICS INC (FBLG) has a profitability rating of 0 / 10.


What is the earnings growth outlook for FIBROBIOLOGICS INC?

The Earnings per Share (EPS) of FIBROBIOLOGICS INC (FBLG) is expected to decline by -37.5% in the next year.